Name of the Project
Medicago production facility project.
Location
Quebec City, Canada.
Client
Medicago.
Project Description
The facility will regroup Medicago’s head office and consolidate all its current Canadian operations.
The vaccine developer’s facility will house research and development activities and commercial production in the city's Estimauville innovation park. Once complete, the 44 000 m2 fully automated facility will house manufacturing, offices, laboratories, a greenhouse, a pilot plant and support services.
The facility will have the capacity to deliver up to 40-million to 50-million doses of quadrivalent seasonal flu vaccines and also work towards developing new products.
Jobs to be Created
The project will create 200 new high-skilled jobs, adding to the team of 180 employees already working at Medicago’s Quebec City office and laboratories.
Value
$245-million.
Duration
Construction is expected to begin later this year and to be completed by 2019.
Latest Developments
SNC-Lavalin has been awarded a $12.5-million contract by Medicago to provide design services for the new production facility.
SNC-Lavalin will perform preliminary and detailed engineering services, procurement of equipment critical to
the process fabrication and the complete supply of automation integration services.
Key Contracts and Suppliers
SNC-Lavalin (design and services).
On Budget and on Time?
Not stated.
Contact Details for Project Information
Medicago media contact Michelle O’Brodovich tel +1 418 529 3223 ext 32 or email mobrodovich@tactconseil.ca.